Department of Radiology, Cancer Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Zhejiang, Hangzhou, China.
Department of Gastroenterology, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.
BMC Surg. 2023 Aug 17;23(1):239. doi: 10.1186/s12893-023-02139-8.
Preoperative prediction of microvascular invasion (MVI) using a noninvasive method remain unresolved, especially in HBV-related in intrahepatic cholangiocarcinoma (ICC). This study aimed to build and validate a preoperative prediction model for MVI in HBV-related ICC.
Patients with HBV-associated ICC undergoing curative surgical resection were identified. Univariate and multivariate logistic regression analyses were performed to determine the independent risk factors of MVI in the training cohort. Then, a prediction model was built by enrolling the independent risk factors. The predictive performance was validated by receiver operator characteristic curve (ROC) and calibration in the validation cohort.
Consecutive 626 patients were identified and randomly divided into the training (418, 67%) and validation (208, 33%) cohorts. Multivariate analysis showed that TBIL, CA19-9, tumor size, tumor number, and preoperative image lymph node metastasis were independently associated with MVI. Then, a model was built by enrolling former fiver risk factors. In the validation cohort, the performance of this model showed good calibration. The area under the curve was 0.874 (95% CI: 0.765-0.894) and 0.729 (95%CI: 0.706-0.751) in the training and validation cohort, respectively. Decision curve analysis showed an obvious net benefit from the model.
Based on clinical data, an easy model was built for the preoperative prediction of MVI, which can assist clinicians in surgical decision-making and adjuvant therapy.
使用非侵入性方法预测微血管侵犯(MVI)仍然没有得到解决,尤其是在乙型肝炎病毒(HBV)相关的肝内胆管癌(ICC)中。本研究旨在建立和验证一种用于预测 HBV 相关 ICC 中 MVI 的术前预测模型。
确定接受根治性手术切除的 HBV 相关 ICC 患者。在训练队列中进行单因素和多因素逻辑回归分析,以确定 MVI 的独立危险因素。然后,通过纳入独立的危险因素来建立预测模型。在验证队列中通过接受者操作特征曲线(ROC)和校准来验证预测性能。
连续纳入了 626 例患者,并随机分为训练队列(418 例,67%)和验证队列(208 例,33%)。多因素分析显示,TBIL、CA19-9、肿瘤大小、肿瘤数量和术前影像学淋巴结转移与 MVI 独立相关。然后,通过纳入前五个危险因素来建立模型。在验证队列中,该模型显示出良好的校准性能。在训练和验证队列中,曲线下面积分别为 0.874(95%CI:0.765-0.894)和 0.729(95%CI:0.706-0.751)。决策曲线分析显示该模型具有明显的净收益。
基于临床数据,建立了一种用于预测 MVI 的简便模型,可帮助临床医生进行手术决策和辅助治疗。